<DOC>
	<DOC>NCT01411254</DOC>
	<brief_summary>This study will evaluate the efficacy and safety of Betamethasone Microsphere (DE-102) for diabetic macular edema.</brief_summary>
	<brief_title>Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA)</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<criteria>Provided signed, written informed consent 20 years of age or older with diabetic macular edema Active proliferative diabetic retinopathies (PDR) in the study eye Uncontrolled diabetes mellitus and hypertension Known steroidresponder</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>DME</keyword>
</DOC>